32
Views
5
CrossRef citations to date
0
Altmetric
Original Article

Complexity of Human Immune Response Profiles for CD4+ T Cell Epitopes from the Diabetes Autoantigen GAD65

, , , , , & show all
Pages 231-240 | Received 06 Nov 2000, Accepted 12 Feb 2001, Published online: 07 Jul 2009

References

  • Lernmark A. Glutamic acid decarboxylase‐gene to antigen to disease. Journal of Internal Medicine 1996; 240: 259–77
  • Endl J, Otto H, Jung G, Dreisbusch B, Donie F, Stahl P, et al. Identification of naturally processed T cell epitopes from glutamic acid decarboxylase presented in the context of HLA.‐DR alleles by T lymphocytes of recent onset IDDM patients. J. Clin. Invest 1997; 99: 2405–15
  • Bach J M, Otto H, Nepom G T, Jung G, Cohen H, Timsit J, et al. High affinity presentation of an autoantigenic peptide in type I diabetes by an HLA class II protein encoded in a hap‐lotype protecting from disease. Journal of Autoimmunity 1997; 10: 375–86
  • Panina‐Bordignon P, Lang R, van Endert P M, Benazzi E, Felix A M, Pastore R M, et al. Cytotoxic T cells specific for glutamic acid decarboxylase in autoimmune diabetes. J. Exp. Med 1995; 181: 1923–7
  • Tabata H, Kanai T, Yoshizumi H, Nishiyama S, Fujimoto S, Matsuda I, et al. Characterization of self‐glutamic acid decarboxylase 65‐reactive CD4+ T‐cell clones established from Japanese patients with insulin‐dependent diabetes mellitus. Hum. Immunol 1998; 59: 549–60
  • Ou D, Tingle A J, Metzger D L, Tingle A J. CD4+ and CD8+ T‐cell clones from congenital rubella syndrome patients with IDDM recognize overlapping GAD65 protein epitopes. Implications for HLA class I and II allelic linkage to disease susceptibility. Hum. Immunol 1999; 60: 652–64
  • Lohmann T, Londei M. T cell clones to epitopes of glutamic acid decarboxylase 65 raised from normal subjects and patients with insulin‐dependent diabetes. Journal of Autoimmunity 1996; 9: 385–9
  • Atkinson M A, Kaufman D L, Campbell L, Gibbs K A, Shah S C, Bu D ‐F, et al. Response of peripheral‐blood mononuclear cells to glutamate decarboxylase in insulin‐dependent diabetes. Lancet 1992; 339: 458–9
  • Durinovic‐Bello I, Hummel M, Ziegler A ‐G. Cellular immune response to diverse islet cell antigens in I. D. D. M. Diabetes 1996; 45: 795–800
  • Worsaae A, Hejnaes K, Moody A, Ludvigsson J, Pociot F, Lorenzen T, et al. T cell proliferative responses to glutamic acid decarboxylase‐65 in IDDM are negatively associated with HLA DR3/4. Autoimmunity 1995; 22: 183–9
  • Roep B O, Atkinson M A, van Endert P M, Gottlieb P A, Wilson S B, Sachs J A. Autoreactive T cell Responses in Insulin‐dependent (Type 1) Diabetes Mellitus. Report of the First International Workshop for Standardization of T cell assays. Journal of Autoimmunity 1999; 13: 267–82
  • Reijonen H, Elliott J F, van Endert P, Nepom G. Differential presentation of glutamic acid decarboxylase (GAD65) T‐cell epitopes among HLA.‐DRB1 0401 positive individuals. Journal of Immunology 1999; 163: 1674–81
  • Lohmann T, Leslie R D G, Hawa M, Geysen M, Rodda S, Londei M. Immunodominant epitopes of glutamic acid decarboxylase 65 and 67 in insulin‐dependent diabetes mellitus. Lancet 1994; 343: 1607–8
  • Rharbaoui F, Mayer A, Granier C, Bouanani M, Thivolet C, Pau B, et al. T cell response pattern to glutamic acid decarboxylase 65 (GAD65) peptides of newly diagnosed type 1 diabetic patients sharing susceptible HLA haplotypes. Clinical and Experimental Immunology 1999; 117: 30–7
  • Armstrong N W, Jones D B. Epitopes of GAD 65 in insulin‐dependent diabetes mellitus. Lancet 1994; 344: 406–7
  • Boyton R J, Lohmann T, Londei M, Kalbacher H, Haider T, Frater A J, et al. Glutamic acid decarboxylase T lymphocyte responses associated with susceptibility or resistance to type I diabetes: analysis in disease discordant human twins, non‐obese diabetic mice and HLA.‐DQ transgenic mice. International Immunology 1998; 10: 1765–76
  • Wicker L S, Chen S ‐L, Nepom G T, Elliott J F, Freed D C, Bansal A, et al. Naturally processed T cell epitopes from human Glutamic Acid Decarboxylase identified using mice transgenic for the type 1 diabetes‐associated human MHC class II allele, DRB1 0401. J. Clin. Invest 1996; 98: 2597–603
  • Patel S D, Cope A P, Congia M, Chen T T, Kim E, Fugger L, et al. Identification of immunodominant T cell epitopes of human glutamic acid decarboxylase 65 by using HLA.‐DR (alphal 0101, beta10401) transgenic mice. Proceedings of the National Academy of Sciences USA 1997; 94: 8082–7
  • Rowe R E, Leech N J, Nepom G T, McCulloch D K. High genetic risk for insulin‐dependent diabetes in the Pacific Northwest: first report from the Washington State Diabetes Prediction Study. Diabetes 1994; 43: 87–94
  • Woo W, LaGasse J M, Zhou Z, Patel R, Palmer J P, Campus H, et al. A novel high‐throughput method for accurate, rapid, and oconomical measurement of multiple type 1 diabetes autoantibodies. J. Immunol. Methods 2000; 244: 91–103
  • Karlsen A E, Hagopian W A, Grubin C E, Dube S, Disteche C M, Adler D A, et al. Cloning and primary structure of a human islet isoform of glutamic acid decarboxylase from chromosome 10. Proc. Natl. Acad. Sci. U. S.A 1991; 88: 8337–41
  • Rabin D U, Pleasic S M, Shapiro J A, Yoo‐Warren H, Oles J, Hicks J M, et al. Islet cell antigen 512 is a diabetes‐specific islet autoantigen related to protein tyrosine phosphatases. Journal of Immunology 1994; 152: 3183–8
  • Nepom G T, Lippolis J D, White F M, Masewicz S, Marto J A, Herman A, et al. Identification and modulation of a naturally processed T‐cell epitope from the diabetes‐associated autoantigen hGAD65. Proceedings of the National. Academy of Sciences USA 2001; 98: 1763–68
  • Falorni A, Ackefors M, Carlberg C, Daniels T, Persson B, Robertson J, et al. Diagnostic sensitivity of immunodominant epitopes of glutamic acid decarboxylase (GAD65) autoantibodies epitopes in childhood I. D. D. M. Diabetologia 1996; 39: 1091–8
  • Hagopian W A, Sanjeevi C B, Kockum I, Landin‐Olsson M, Karlsen A E, Sundkvist G, et al. Glutamate decarboxylase‐, insulin‐, and islet cell‐antibodies and HLA typing to detect diabetes in a general population‐based study of Swedish children. J. Clin. Invest 1995; 95: 1505–11

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.